Concerns Rise as Moderna's Stock Drops Amid RFK Jr.'s Nomination for Health Secretary
Moderna Stock Dumps After RFK Advances To Full Senate Vote 🔗
Moderna's stock dropped by 5.5% after Robert F. Kennedy Jr. advanced to a full Senate vote for the position of Secretary of Health and Human Services. His nomination received support from Sen. Bill Cassidy, who previously expressed concerns about Kennedy's anti-vaccine stance but ultimately voted in favor after discussions with the White House. Kennedy's nomination faces uncertainty in the full Senate, despite Republican control. The situation raises concerns for Moderna and other vaccine manufacturers amidst the ongoing debate over vaccine policies.
What caused Moderna's stock to drop?
The stock fell by 5.5% after Robert F. Kennedy Jr. advanced his nomination for Secretary of Health and Human Services, which raised concerns among investors regarding vaccine policies.
Who supported RFK's nomination despite previous reservations?
Sen. Bill Cassidy supported Kennedy's nomination, voting in favor after having intense discussions with both Kennedy and the White House, despite earlier concerns regarding Kennedy's vaccine views.
What is the current political climate regarding Kennedy's nomination?
Kennedy's nomination is uncertain as he may not have enough votes for passage in the Senate, despite the Republican majority of 53-47.